BELZUTIFAN
Manner of administration:Oral
Restriction
Indication: Von Hippel-Lindau (VHL) disease
Treatment phase: Initiating or recommencing treatment
Restriction
Indication: Von Hippel-Lindau (VHL) disease
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 90 | # of repeats: 5 | DPMQ: $22,222.93 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Welireg | |||||